445026388
19 Jun 2019
Switzerland New Sandoz biosimilar adalimumab data confirms switching from reference biologic has no impact on safety or efficacy, Switzerland
N/A
Banking, Finance, Insurance and Securities (BFIS) Tenders , Healthcare and Medical Tenders
Procurement News
Click for more details
If you have forgotten your User ID or Password, then please contact the TendersInfo Customercare by Email on customercare@tendersinfo.com.